EC opens formal investigation into Aspen Pharma’s cancer drug price hikes
17 May 2017 | By Niamh Marriott, Junior Editor
The EC has opened a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines...